Allylestrenol
Spécifications
432-60-0Numéro CAS
207-082-9Numéro CE
(8R,9S,10R,13S,14S,17R)-13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-olNom IUPAC
C21H32OFormule chimique
300.5 g/molMasse molaire
allylestrenol; 432-60-0; Gestanin; Allyloestrenol; Orageston; Perselin; Organon; Alilestrenol; 17alpha-Allylestr-4-en-17beta-ol; DTXSID9022574; Allilestrenolo; Allylestrenolum; I47VB5DZ8O; NSC-37723; 17-(2-Propenyl)estr-4-en-17-ol; 17-Hydroxy-17-alpha-allyl-4-estrene; 17-alpha-Allyl-17-beta-hydroxy-4-estrene; 17-alpha-Allyl-3-deoxy-19-nortestosterone; 19-norpregn-4-ene-20-yn-17beta-ol; DTXCID902574; NSC37723; RefChem:554916; G03DC01; 207-082-9; Gestanon; Gestanol; Turinal; Gestanyn; Estrenol, allyl-; 17alpha-Allyl-4-estren-17beta-ol; MFCD00198957; (8R,9S,10R,13S,14S,17R)-13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol; Estr-4-en-17-ol, 17-(2-propenyl)-, (17b)-; 17.alpha.-Allylestr-4-en-17.beta.-ol; Allyloestrenolum; 17-alpha-Allylestr-4-en-17-beta-ol; 17alpha-Allylestrenol; Allilestrenolo [DCIT]; Gestanon-r; Alilestrenol [INN-Spanish]; Allylestrenolum [INN-Latin]; Perselin (TN); 17.alpha.-Allylestrenol; 17alpha-Allyl-4-destrene-17beta-ol; 17alpha-Allyl-4-oestrene-17beta-ol; Allylestrenol (JAN/INN); 17-alpha-Allyl-4-oestrene-17-beta-ol; 17alpha-Allyl-17beta-hydroxy-4-estrene; 17alpha-Allyl-3-deoxy-19-nortestosterone; Allyl estrenol; CCRIS 9068; 17-alpha-Allylhydroxy-19-nor-4-androstene; 3-Deoxy-17-alpha-allyl-19-nortestosterone; 17-allylestr-4-en-17-beta-ol; ATXHVCQZZJYMCF-XUDSTZEESA-N; NCGC00159497-02; 21-Methylene-19-nor-17-alpha-preg-4-en-17-ol; EINECS 207-082-9; Estr-4-en-17beta-ol, 17-allyl-; 17-alpha-Allyl-17-beta-hydroxy-delta(sup 4)-estren; 17alpha-Allyl-19-nor-delta-4-androstene-17beta-ol; NSC 37723; Estr-4-en-17-ol, 17-(2-propenyl)-, (17beta)-; BRN 3148038; 17.alpha.-Allyl-4-estren-17.beta.-ol; 17.alpha.-Allyl-4-destrene-17.beta.-ol; 17.alpha.-Allyl-4-oestrene-17.beta.-ol; ESTR-4-EN-17-beta-OL, 17-ALLYL-; 17.alpha.-Allyl-3-deoxy-19-nortestosterone; 17.alpha.-Allyl-17.beta.-hydroxy-4-estrene; ALLYLESTRENOL [MI]; UNII-I47VB5DZ8O; ALLYLESTRENOL [INN]; ALLYLESTRENOL [JAN]; (17beta)-17-prop-2-en-1-ylestr-4-en-17-ol; ALLYLESTRENOL [MART.]; SCHEMBL329623; 19-Nor-17-alpha-preg-4-en-17-ol, 21-methylene-; ALLYLESTRENOL [WHO-DD]; Allylestrenol [INN:BAN:JAN]; orb1305318; CHEMBL3185133; SCHEMBL17891654; CHEBI:31189; 17.alpha.-Allyl-17-.beta.-hydroxy-.delta.(sup 4)-estren; Tox21_111718; LMST02030125; s5219; AKOS015964938; DB01431; DS-8255; Estr-4-en-17-ol, (17.beta.)-; FA55289; Estr-4-en-17.beta.-ol, 17-allyl-; CAS-432-60-0; HY-17375; SY108284; 3-deketo-17alpha-allyl-19-nortestosterone; A2570; CS-0006769; NS00031328; WLN: L E5 B666 MUTJ E1 FQ F2U1; D01374; 4-06-00-04143 (Beilstein Handbook Reference); F463580; Q531965; SR-01000883956; SR-01000883956-1; BRD-K12872829-001-01-0; (1R,3aS,3bR,9aR,9bS,11aS)-11a-Methyl-1-(prop-2-en-1-yl)-2,3,3a,3b,4,5,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-cyclopenta[a]phenanthren-1-ol; (8R,9S,10R,13S,14S,17R)-17-allyl-13-methyl-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ol; (8R,9S,10R,13S,14S,17R)-17-allyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol; 13-Methyl-17-prop-2-enyl-2,3,6,7,8,9,1,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-olSynonymes
Produits contenant Allylestrenol
Entreprises vendant Allylestrenol
CT
Công ty cổ phần sinh học dược phẩm Ba ĐìnhViet NamZX
Zhejiang Xianju Junye Pharmaceutical Co.,Ltd.ChinaSP
STARWAY PHARM Co., Ltd.ChinaJG
JIANSGU GRAND XIANLE PHARMACEUTICAL CO.,LTD.ChinaAC
AFINE CHEMICALS LIMITED